Sight Sciences, Inc. (SGHT): Cost of Revenue
$10.70M
Year ended 2025-12-31
$10.04M
Trailing 12 months to 2026-06-30
-4.7%
3-year compound annual growth
+3.0%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.70M | -7.6% | 2026-03-04, From 2025-01-01 |
| 2024-12-31 | $11.58M | -2.5% | 2026-03-04, From 2024-01-01 |
| 2023-12-31 | $11.88M | -3.9% | 2025-03-07, From 2023-01-01 |
| 2022-12-31 | $12.36M | +43.6% | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | $8.61M | -6.5% | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | $9.21M | n/a | 2022-03-24, From 2020-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | 2025-12-31 | $10.70M | -7.6% |
| PRO DEX Inc (PDEX) | 2026-06-30 | $53.21M | +13.0% |
| AVITA Medical, Inc. (RCEL) | 2025-12-31 | $12.79M | +40.7% |
| Iradimed Corp (IRMD) | 2025-12-31 | $19.49M | +15.4% |
| Delcath Systems, Inc. (DCTH) | 2025-12-31 | $11.80M | +90.6% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $23.36M | +7.2% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $46.26M | +29.9% |
| Meihua International Medical Technologies Co., Ltd. (MHUAF) | 2025-12-31 | $42.63M | -33.0% |
| NeuroPace Inc (NPCE) | 2025-12-31 | $22.77M | +9.3% |
Compare SGHT, PDEX, RCEL, IRMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗